Logo image of 1TSLA.MI

TESLA INC (1TSLA.MI) Stock Fundamental Analysis

BIT:1TSLA - Borsa Italiana Milan - US88160R1014 - Common Stock - Currency: EUR

370.2  -3.85 (-1.03%)

Fundamental Rating

5

Overall 1TSLA gets a fundamental rating of 5 out of 10. We evaluated 1TSLA against 29 industry peers in the Automobiles industry. While 1TSLA has a great health rating, its profitability is only average at the moment. 1TSLA is valued quite expensive, but it does show an excellent growth. These ratings could make 1TSLA a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

1TSLA had positive earnings in the past year.
1TSLA had a positive operating cash flow in the past year.
In the past 5 years 1TSLA has always been profitable.
1TSLA had a positive operating cash flow in each of the past 5 years.
1TSLA.MI Yearly Net Income VS EBIT VS OCF VS FCF1TSLA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

1TSLA has a better Return On Assets (5.84%) than 70.37% of its industry peers.
With a Return On Equity value of 9.78%, 1TSLA perfoms like the industry average, outperforming 48.15% of the companies in the same industry.
1TSLA's Return On Invested Capital of 6.62% is in line compared to the rest of the industry. 1TSLA outperforms 55.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1TSLA is above the industry average of 8.71%.
The last Return On Invested Capital (6.62%) for 1TSLA is well below the 3 year average (11.83%), which needs to be investigated, but indicates that 1TSLA had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.84%
ROE 9.78%
ROIC 6.62%
ROA(3y)11.73%
ROA(5y)9.08%
ROE(3y)20.62%
ROE(5y)16.66%
ROIC(3y)11.83%
ROIC(5y)10.37%
1TSLA.MI Yearly ROA, ROE, ROIC1TSLA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

Looking at the Profit Margin, with a value of 7.30%, 1TSLA is in line with its industry, outperforming 59.26% of the companies in the same industry.
In the last couple of years the Profit Margin of 1TSLA has declined.
1TSLA has a worse Operating Margin (7.94%) than 70.37% of its industry peers.
In the last couple of years the Operating Margin of 1TSLA has grown nicely.
With a Gross Margin value of 17.86%, 1TSLA is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of 1TSLA has grown nicely.
Industry RankSector Rank
OM 7.94%
PM (TTM) 7.3%
GM 17.86%
OM growth 3Y-13.01%
OM growth 5Y89.45%
PM growth 3Y-10.74%
PM growth 5YN/A
GM growth 3Y-10.93%
GM growth 5Y1.53%
1TSLA.MI Yearly Profit, Operating, Gross Margins1TSLA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1TSLA is still creating some value.
1TSLA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1TSLA has been increased compared to 5 years ago.
1TSLA has a worse debt/assets ratio than last year.
1TSLA.MI Yearly Shares Outstanding1TSLA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
1TSLA.MI Yearly Total Debt VS Total Assets1TSLA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

1TSLA has an Altman-Z score of 16.70. This indicates that 1TSLA is financially healthy and has little risk of bankruptcy at the moment.
1TSLA has a Altman-Z score of 16.70. This is amongst the best in the industry. 1TSLA outperforms 100.00% of its industry peers.
The Debt to FCF ratio of 1TSLA is 2.29, which is a good value as it means it would take 1TSLA, 2.29 years of fcf income to pay off all of its debts.
1TSLA's Debt to FCF ratio of 2.29 is amongst the best of the industry. 1TSLA outperforms 92.59% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that 1TSLA is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.08, 1TSLA belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 2.29
Altman-Z 16.7
ROIC/WACC0.57
WACC11.52%
1TSLA.MI Yearly LT Debt VS Equity VS FCF1TSLA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

A Current Ratio of 2.02 indicates that 1TSLA has no problem at all paying its short term obligations.
1TSLA's Current ratio of 2.02 is amongst the best of the industry. 1TSLA outperforms 85.19% of its industry peers.
1TSLA has a Quick Ratio of 1.61. This is a normal value and indicates that 1TSLA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of 1TSLA (1.61) is better than 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.61
1TSLA.MI Yearly Current Assets VS Current Liabilites1TSLA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

More info and screens

7

3. Growth

3.1 Past

1TSLA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.68%.
1TSLA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 103.90% yearly.
1TSLA shows a small growth in Revenue. In the last year, the Revenue has grown by 0.95%.
1TSLA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.78% yearly.
EPS 1Y (TTM)-22.68%
EPS 3Y2.31%
EPS 5Y103.9%
EPS Q2Q%2.82%
Revenue 1Y (TTM)0.95%
Revenue growth 3Y21.98%
Revenue growth 5Y31.78%
Sales Q2Q%2.15%

3.2 Future

1TSLA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.82% yearly.
The Revenue is expected to grow by 18.06% on average over the next years. This is quite good.
EPS Next Y37.82%
EPS Next 2Y30.16%
EPS Next 3Y24.95%
EPS Next 5Y27.82%
Revenue Next Year16.24%
Revenue Next 2Y16.46%
Revenue Next 3Y15.49%
Revenue Next 5Y18.06%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1TSLA.MI Yearly Revenue VS Estimates1TSLA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100B 200B 300B 400B
1TSLA.MI Yearly EPS VS Estimates1TSLA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 10 15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 158.21, which means the current valuation is very expensive for 1TSLA.
Compared to the rest of the industry, the Price/Earnings ratio of 1TSLA indicates a rather expensive valuation: 1TSLA more expensive than 92.59% of the companies listed in the same industry.
1TSLA's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.47.
The Price/Forward Earnings ratio is 114.72, which means the current valuation is very expensive for 1TSLA.
Based on the Price/Forward Earnings ratio, 1TSLA is valued more expensive than 85.19% of the companies in the same industry.
1TSLA is valuated rather expensively when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 158.21
Fwd PE 114.72
1TSLA.MI Price Earnings VS Forward Price Earnings1TSLA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

1TSLA's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. 1TSLA is more expensive than 92.59% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1TSLA indicates a slightly more expensive valuation: 1TSLA is more expensive than 62.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 342.97
EV/EBITDA 89.84
1TSLA.MI Per share data1TSLA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1TSLA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1TSLA's earnings are expected to grow with 24.95% in the coming years.
PEG (NY)4.18
PEG (5Y)1.52
EPS Next 2Y30.16%
EPS Next 3Y24.95%

More info and screens

0

5. Dividend

5.1 Amount

1TSLA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TESLA INC

BIT:1TSLA (2/4/2025, 7:00:00 PM)

370.2

-3.85 (-1.03%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)01-29 2025-01-29/amc
Earnings (Next)N/A N/A
Inst Owners47.13%
Inst Owner ChangeN/A
Ins Owners12.92%
Ins Owner ChangeN/A
Market Cap1188.36B
Analysts66.67
Price Target305.69 (-17.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.9%
Min EPS beat(2)-5.02%
Max EPS beat(2)20.83%
EPS beat(4)1
Avg EPS beat(4)-3.63%
Min EPS beat(4)-18.25%
Max EPS beat(4)20.83%
EPS beat(8)2
Avg EPS beat(8)-3.04%
EPS beat(12)6
Avg EPS beat(12)3.76%
EPS beat(16)10
Avg EPS beat(16)7.81%
Revenue beat(2)0
Avg Revenue beat(2)-5.03%
Min Revenue beat(2)-7.36%
Max Revenue beat(2)-2.7%
Revenue beat(4)1
Avg Revenue beat(4)-3.52%
Min Revenue beat(4)-7.36%
Max Revenue beat(4)0.93%
Revenue beat(8)1
Avg Revenue beat(8)-3.05%
Revenue beat(12)2
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-1.39%
PT rev (1m)7%
PT rev (3m)54.38%
EPS NQ rev (1m)0.69%
EPS NQ rev (3m)-10.61%
EPS NY rev (1m)-0.67%
EPS NY rev (3m)0.22%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)-3.37%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 158.21
Fwd PE 114.72
P/S 12.57
P/FCF 342.97
P/OCF 82.3
P/B 16.84
P/tB 17.19
EV/EBITDA 89.84
EPS(TTM)2.34
EY0.63%
EPS(NY)3.23
Fwd EY0.87%
FCF(TTM)1.08
FCFY0.29%
OCF(TTM)4.5
OCFY1.22%
SpS29.45
BVpS21.98
TBVpS21.53
PEG (NY)4.18
PEG (5Y)1.52
Profitability
Industry RankSector Rank
ROA 5.84%
ROE 9.78%
ROCE 8.32%
ROIC 6.62%
ROICexc 10.89%
ROICexgc 11.18%
OM 7.94%
PM (TTM) 7.3%
GM 17.86%
FCFM 3.67%
ROA(3y)11.73%
ROA(5y)9.08%
ROE(3y)20.62%
ROE(5y)16.66%
ROIC(3y)11.83%
ROIC(5y)10.37%
ROICexc(3y)19.43%
ROICexc(5y)17.56%
ROICexgc(3y)19.79%
ROICexgc(5y)18.13%
ROCE(3y)14.87%
ROCE(5y)13.04%
ROICexcg growth 3Y-20.75%
ROICexcg growth 5Y96.88%
ROICexc growth 3Y-19.54%
ROICexc growth 5Y97.08%
OM growth 3Y-13.01%
OM growth 5Y89.45%
PM growth 3Y-10.74%
PM growth 5YN/A
GM growth 3Y-10.93%
GM growth 5Y1.53%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 2.29
Debt/EBITDA 0.44
Cap/Depr 211.29%
Cap/Sales 11.61%
Interest Coverage 28.01
Cash Conversion 113.67%
Profit Quality 50.22%
Current Ratio 2.02
Quick Ratio 1.61
Altman-Z 16.7
F-Score4
WACC11.52%
ROIC/WACC0.57
Cap/Depr(3y)197.79%
Cap/Depr(5y)201.66%
Cap/Sales(3y)9.87%
Cap/Sales(5y)10.96%
Profit Quality(3y)46.43%
Profit Quality(5y)118.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-22.68%
EPS 3Y2.31%
EPS 5Y103.9%
EPS Q2Q%2.82%
EPS Next Y37.82%
EPS Next 2Y30.16%
EPS Next 3Y24.95%
EPS Next 5Y27.82%
Revenue 1Y (TTM)0.95%
Revenue growth 3Y21.98%
Revenue growth 5Y31.78%
Sales Q2Q%2.15%
Revenue Next Year16.24%
Revenue Next 2Y16.46%
Revenue Next 3Y15.49%
Revenue Next 5Y18.06%
EBIT growth 1Y-12.72%
EBIT growth 3Y6.11%
EBIT growth 5Y149.66%
EBIT Next Year143.16%
EBIT Next 3Y58.13%
EBIT Next 5Y44.23%
FCF growth 1Y-17.81%
FCF growth 3Y0.93%
FCF growth 5Y29.91%
OCF growth 1Y12.58%
OCF growth 3Y9.08%
OCF growth 5Y44.06%